Selected article for: "secondary treatment group and treatment group"

Author: Ha, Seok Gyun; Oh, Kyung Jin; Ko, Kwang-Pil; Sun, Yong Han; Ryoo, Eell; Tchah, Hann; Jeon, In Sang; Kim, Hyo Jeong; Ahn, Jung Min; Cho, Hye-Kyung
Title: Therapeutic Efficacy and Safety of Prolonged Macrolide, Corticosteroid, Doxycycline, and Levofloxacin against Macrolide-Unresponsive Mycoplasma pneumoniae Pneumonia in Children
  • Document date: 2018_9_18
  • ID: yrbo0hdk_21
    Snippet: After the change to the secondary treatment, the TTD was the shortest in the CST group (8.4 ± 26.8 hours) , followed by the LFX (16.8 ± 18 .0 hours) and DXC (27.4 ± 33. 2 hours) groups (Fig. 1) . The numbers of patients who achieved defervescence within 48 hours in CST, DXC, and LFX groups were 31 (96.9%), 12 (85.7%), and 5 (83.3%), respectively (.....
    Document: After the change to the secondary treatment, the TTD was the shortest in the CST group (8.4 ± 26.8 hours) , followed by the LFX (16.8 ± 18 .0 hours) and DXC (27.4 ± 33. 2 hours) groups (Fig. 1) . The numbers of patients who achieved defervescence within 48 hours in CST, DXC, and LFX groups were 31 (96.9%), 12 (85.7%), and 5 (83.3%), respectively (

    Search related documents:
    Co phrase search for related documents
    • CST group and secondary treatment: 1
    • lfx group and secondary treatment: 1
    • patient number and secondary treatment: 1